Among these, interleukin 6 (IL-6), with significantly high levels in patients with MS [2], seems to be directly related to demyelination, since an increase in IL-6 receptors has been seen in CD4+ T cells of patients with MS, involved in the pathogenesis of the disease [3]. Here, CD4 is linked to myeloid sarcoma.